In focus · trending topic

Otitis externa

8 stories · following the connections

Otonomy Reports Third Quarter 2017 Financial Results and Provides Corporate Update

By Nasdaq OMXNov 8, 2017, 9:12 PM UTC

Otonomy Reports Positive Results from AVERTS-2 Phase 3 Trial of OTIVIDEX™ in Patients with Ménière's Disease

By Nasdaq OMXNov 8, 2017, 9:06 PM UTC

Otonomy to Report Third Quarter 2017 Financial Results and Provide Corporate Update

By Nasdaq OMXNov 1, 2017, 8:06 PM UTC

Otonomy Provides Business and Financial Update

By Nasdaq OMXSep 13, 2017, 11:30 AM UTC

Otonomy Reports First Quarter 2017 Financial Results and Provides Corporate Update

By Nasdaq OMXMay 4, 2017, 8:27 PM UTC

Otonomy to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update

By Nasdaq OMXFeb 24, 2017, 12:30 PM UTC

Otonomy Holds Investor and Analyst Day and Provides Corporate Update

By Nasdaq OMXOct 7, 2016, 12:00 PM UTC

Otonomy Announces Phase 3 Clinical Trial Plan for OTIPRIO™ in Otitis Externa Patients Based on Successful End-of-Phase 2 Review by FDA

By Nasdaq OMXApr 18, 2016, 11:30 AM UTC